4 results
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... suspension 400 mg PO BID ... Systemic antifungals are ... candida #mucosal #IDSA ... infections #HIVAIDS #pharmacology
Diagnosis and Management of Achalasia - ACG Guidelines

Who to suspect?
 • Patients presenting with progressive dysphagia
with GERD who are ... Pneumatic Dilation (PD ... POEM Symptomatic Treatment ... Botulinum toxin • Pharmacologic ... gastroenterology #Treatemtn
Lithium Therapy for Bipolar Disorder 
Toxicity Levels: 
 - Mild (1-1.5 mEq/L) 
 - Moderate (1.6-2.5
maintenance agent for treatment ... If levels are high ... , patients are at ... Bipolar #Disorder #BPD ... #Toxicity #Pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... concentrations are ... Valganciclovir 900 mg PO BID ... Cytomegalovirus #CMV #IDSA ... infections #HIVAIDS #pharmacology